Hamilton Lane Incorporated (HLNE) Financials

HLNE

Trailing 12 months to June 30, 2026

Revenue $858.4M +24.0% YoY

Net Income $275.9M +30.0% YoY

Free Cash Flow $366.8M +8.5% YoY

Operating Cash Flow $373.1M +6.6% YoY

Market Cap $5.5B as of Oct 23, 2026

Price / Sales 6.4x on $858.4M revenue, trailing 12 months to June 30, 2026

Price / Earnings 20.0x on $275.9M net income, trailing 12 months to June 30, 2026

Price / Book 5.9x on $939.3M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HLNE SEC filings page.

Hamilton Lane Incorporated (HLNE) reported $858.4M in revenue over the twelve months to Jun 30, 2026, up 24.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HLNE FY2026 2026-10-04

Cash conversion strengthened sharply as earnings scaled, while the balance sheet expanded without a proportional rise in debt relative to equity.

Between FY2024 and FY2026, net income rose 76.9% while free-cash-flow margin nearly tripled, showing that cash generation improved much faster than reported profitability. In FY2026, free cash flow reached $419M against operating cash flow of $425M, indicating that earnings were accompanied by cash rather than mainly accounting accruals.

Revenue expanded 37.0% from FY2024 to FY2026, while net margin widened materially. The earnings model scaled better than the top line alone suggests, although the reported lines do not isolate whether mix or cost structure drove that improvement.

From FY2024 to FY2026, total assets grew 81.3% while total liabilities grew 133.5%. Even so, debt-to-equity fell from 0.4x to 0.3x, so the balance-sheet expansion was not simply a conventional debt build; equity grew alongside it.

Financial Health Signals

Financial Health Score (4 of 6 dimensions) 84/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Hamilton Lane Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

Hamilton Lane Incorporated's revenue grew 6.5% year-over-year to $759.0M, a solid pace of expansion. This earns a growth score of 78/100.

Leverage

Hamilton Lane Incorporated carries a low D/E ratio of 0.30, meaning only $0.30 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 69/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

n/a

Not available for Hamilton Lane Incorporated, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Cash Flow

Hamilton Lane Incorporated converts 55.2% of revenue into free cash flow ($419.1M). This strong cash generation earns a score of 98/100.

Returns

n/a

Not available for Hamilton Lane Incorporated, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Piotroski F-Score Partial

4/6

Hamilton Lane Incorporated passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality Cash-Backed

1.71x

For every $1 of reported earnings, Hamilton Lane Incorporated generates $1.71 in operating cash flow ($424.9M OCF vs $249.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$275.3M

YoY+56.5%

QoQ+42.2%

5Y CAGR+28.4%

Hamilton Lane Incorporated generated $275.3M in revenue in Q1 2027. This represents an increase of 56.5% from the same quarter a year earlier. Against the prior quarter it is up 42.2%.

Net Income

$80.5M

YoY+49.7%

QoQ+21.6%

5Y CAGR+23.4%

10Y CAGRn/m

Hamilton Lane Incorporated reported $80.5M in net income in Q1 2027. This represents an increase of 49.7% from the same quarter a year earlier. Against the prior quarter it is up 21.6%.

EBITDA

Not reported for Q1 2027.

EPS (Diluted)

Not reported for Q1 2027.

Cash & Balance Sheet

Free Cash Flow

$75.3M

YoY-40.9%

QoQ-25.6%

5Y CAGR+22.0%

10Y CAGR+16.0%

Hamilton Lane Incorporated generated $75.3M in free cash flow in Q1 2027, representing cash available after capex. This represents a decrease of 40.9% from the same quarter a year earlier. Against the prior quarter it is down 25.6%.

Cash & Debt

$349.7M

YoY+8.6%

QoQ-6.0%

5Y CAGR+35.6%

10Y CAGR+18.6%

Hamilton Lane Incorporated held $349.7M in cash against $274.2M in long-term debt as of Q1 2027.

Dividends Per Share

Not reported for Q1 2027.

Shares Outstanding

Not reported for Q1 2027.

Margins & Returns

Net Margin

29.2%

YoY-1.3pp

QoQ-5.0pp

5Y change-6.4pp

Hamilton Lane Incorporated's net profit margin was 29.2% in Q1 2027, showing the share of revenue converted to profit. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.0 percentage points.

Return on Equity

8.6%

YoY+1.5pp

QoQ+1.3pp

5Y change-2.5pp

Hamilton Lane Incorporated's quarterly ROE was 8.6% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Gross Margin

Not reported for Q1 2027.

Operating Margin

Not reported for Q1 2027.

Capital Allocation

Capital Expenditures

$1.8M

YoY+34.0%

QoQ+3.2%

5Y CAGR-16.9%

10Y CAGR+17.4%

Hamilton Lane Incorporated invested $1.8M in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 34.0% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.

R&D Spending

Not reported for Q1 2027.

Share Buybacks

Not reported for Q1 2027.

HLNE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HLNE quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Revenue	$858.4M	$759.0M+6.5%	$713.0M+28.7%	$553.8M+4.7%	$528.8M+43.7%	$367.9M+7.7%	$341.6M+24.7%	$274.0M+8.7%	$252.2M+3.3%	$244.0M+35.7%	$179.8M	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$49.2M-14.4%	$57.5M+17.4%	$49.0M	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	$2.0M-27.4%	$2.8M-7.3%	$3.0M-49.3%	$6.0M-58.9%	$14.6M+15.2%	$12.6M
Income Tax	$81.9M	$75.2M+55.0%	$48.5M-10.9%	$54.5M-1.8%	$55.4M-16.6%	$66.4M+172.0%	$24.4M+74.8%	$14.0M-54.3%	$30.6M-8.3%	$33.3M+10448.4%	$316K-63.6%	$869K
Net Income	$275.9M	$249.2M+14.6%	$217.4M+54.4%	$140.9M+29.1%	$109.1M-25.3%	$146.0M+48.9%	$98.0M+61.2%	$60.8M+81.2%	$33.6M+93.6%	$17.3M+2733.5%	$612Kn/m	$0
EPS (Diluted)	—	N/A	N/A	N/A	N/A	$3.98+41.6%	$2.81+30.7%	$2.15+53.6%	$1.40	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$275.3M+56.5%	$193.6M-2.2%	$198.6M+18.0%	$190.9M+27.3%	$176.0M-10.6%	$198.0M+12.1%	$168.3M+34.3%	$150.0M+18.2%
Income Tax	$25.1M+36.5%	$15.6M+4.3%	$27.3M+114.7%	$14.0M+1092.7%	$18.4M-6.6%	$15.0M-26.7%	$12.7M-19.6%	$1.2M-36.9%
Net Income	$80.5M+49.7%	$66.2M+31.0%	$58.4M+10.2%	$70.9M+28.9%	$53.7M-8.9%	$50.5M+4.4%	$53.0M+171.6%	$55.0M+30.9%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

HLNE Balance Sheet

HLNE quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Total Assets	$2.3B+36.4%	$1.7B+33.0%	$1.3B+11.5%	$1.1B-11.9%	$1.3B+13.9%	$1.1B+140.0%	$473.5M+31.3%	$360.6M+22.7%	$293.8M+22.1%	$240.6M	N/A
Cash & Equivalents	$371.9M+31.1%	$283.6M+137.1%	$119.6M+2.6%	$116.6M+53.0%	$76.2M-12.4%	$87.0M+73.6%	$50.1M+1.6%	$49.4M+3.7%	$47.6M+47.4%	$32.3M-54.1%	$70.4M
Goodwill	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M+142.6%	$3.9M0.0%	$3.9M0.0%	$3.9M0.0%	$3.9M+268.8%	$1.1M	N/A
Total Liabilities	$1.4B+81.3%	$766.5M+28.8%	$595.2M+5.1%	$566.4M-40.3%	$948.1M+5.5%	$898.4M+280.5%	$236.1M+23.7%	$190.9M+21.0%	$157.7M+2.4%	$154.0M	N/A
Long-Term Debt	$278.4M-4.1%	$290.3M+48.0%	$196.2M-8.1%	$213.5M0.0%	$213.5M+30.9%	$163.2M+118.3%	$74.7M+5.3%	$71.0M-15.7%	$84.2M-0.2%	$84.3M	N/A
Total Equity	$915.2M+27.6%	$717.3M+36.6%	$525.2M+26.4%	$415.4M+19.8%	$346.9M+45.7%	$238.1M+53.8%	$154.8M+40.4%	$110.2M+40.5%	$78.4M+30.6%	$60.0M	N/A
Retained Earnings	$614.7M	N/A	N/A	N/A	N/A	N/A	N/A	$17.7M+288.8%	$4.5M+643.3%	$612K	N/A

Metric	Q1'2710-Q	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$2.5B+40.9%	$2.3B+36.4%	$2.2B+36.4%	$2.0B+39.0%	$1.8B+31.4%	$1.7B+33.0%	$1.6B+31.6%	$1.4B+4.8%
Cash & Equivalents	$349.7M+8.6%	$371.9M+31.1%	$348.0M+6.3%	$334.4M+43.6%	$322.1M+88.3%	$283.6M+137.1%	$327.3M+93.2%	$232.8M-0.8%
Goodwill	N/A	$9.6M0.0%	N/A	N/A	N/A	$9.6M0.0%	N/A	N/A
Total Liabilities	$1.6B+98.2%	$1.4B+81.3%	$1.3B+77.4%	$822.3M+32.1%	$807.0M+27.1%	$766.5M+28.8%	$729.0M+24.7%	$622.4M-30.5%
Long-Term Debt	$274.2M-5.0%	$278.4M-4.1%	$279.5M-4.3%	$285.6M+46.5%	$288.6M+47.6%	$290.3M+48.0%	$292.0M+48.4%	$195.0M-1.2%
Total Equity	$939.3M+23.8%	$915.2M+27.6%	$877.4M+35.1%	$825.8M+36.1%	$758.8M+34.0%	$717.3M+36.6%	$649.3M+38.7%	$606.6M+31.1%
Retained Earnings	$670.5M	$614.7M	N/A	N/A	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

HLNE Cash Flow Statement

HLNE quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Operating Cash Flow	$373.1M	$424.9M+41.3%	$300.8M+148.9%	$120.9M-46.7%	$226.6M+33.7%	$169.5M-9.9%	$188.2M+61.7%	$116.4M+4.3%	$111.6M+15.4%	$96.7M+18.4%	$81.7M-25.2%	$109.2M
Depreciation & Amortization	N/A	$9.9M+6.4%	$9.3M+13.4%	$8.2M+10.0%	$7.4M+35.5%	$5.5M+32.9%	$4.1M+25.6%	$3.3M+10.5%	$3.0M+57.5%	$1.9M-1.3%	$1.9M-5.5%	$2.0M
Stock-Based Compensation	N/A	$50.9M+62.0%	$31.4M+158.9%	$12.1M+21.9%	$9.9M+34.4%	$7.4M+4.6%	$7.1M-1.4%	$7.2M+12.6%	$6.4M+15.1%	$5.5M+18.4%	$4.7M+25.5%	$3.7M
Capital Expenditures	$6.3M	$5.8M-51.9%	$12.2M+9.8%	$11.1M+133.3%	$4.7M-44.3%	$8.5M-54.3%	$18.6M+842.2%	$2.0M-63.1%	$5.4M+138.1%	$2.3M+76.8%	$1.3M+38.4%	$921K
Free Cash Flow	$366.8M	$419.1M+45.2%	$288.7M+163.0%	$109.8M-50.5%	$221.8M+37.8%	$161.0M-5.0%	$169.5M+48.2%	$114.4M+7.7%	$106.3M+12.5%	$94.4M+17.5%	$80.4M-25.7%	$108.3M
Investing Cash Flow	-$547.9M	-$494.8Mn/m	-$117.6Mn/m	-$122.2M-168.7%	$177.9Mn/m	-$70.5Mn/m	-$421.8Mn/m	-$49.9Mn/m	-$19.2Mn/m	-$21.8Mn/m	-$16.7M-768.1%	$2.5M
Financing Cash Flow	$200.3M	$155.8Mn/m	-$19.2M-535.5%	$4.4Mn/m	-$364.1Mn/m	-$113.2M-141.8%	$270.7Mn/m	-$64.7Mn/m	-$90.2Mn/m	-$59.7Mn/m	-$101.2Mn/m	-$110.1M
Dividends Paid	$90.0M	$87.7M+15.4%	$76.0M+16.2%	$65.4M-9.7%	$72.4M+45.9%	$49.6M+25.1%	$39.7M+36.5%	$29.1M+55.6%	$18.7M+96.4%	$9.5Mn/m	$0n/m	$0
Share Buybacks	N/A	N/A	$2K0.0%	$2Kn/m	$0-100.0%	$1K-80.0%	$5K+150.0%	$2K0.0%	$2K0.0%	$2K	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	$77.2M-40.2%	$103.0M+162.1%	$74.1M+15.1%	$118.9M+1.3%	$128.9M+61.7%	$39.3M+80.9%	$64.4Mn/m	$117.4M+51.3%
Depreciation & Amortization	$2.5M0.0%	$2.4M+8.2%	$2.4M+1.8%	$2.5M+6.4%	$2.5M+9.3%	$2.2M-8.0%	$2.4M+17.0%	$2.4M+27.1%
Stock-Based Compensation	$12.9M+0.8%	N/A	$13.0M+10.2%	$12.4M+165.1%	$12.8M+297.1%	N/A	$11.8M+261.1%	$4.7M+49.9%
Capital Expenditures	$1.8M+34.0%	$1.7M-49.3%	$1.7M-70.4%	$1.1M-31.0%	$1.3M-10.8%	$3.4M+113.9%	$5.6M+76.7%	$1.6M-45.6%
Free Cash Flow	$75.3M-40.9%	$101.2M+182.5%	$72.4M+23.3%	$117.8M+1.7%	$127.6M+63.1%	$35.8M+78.3%	$58.8Mn/m	$115.8M+55.0%
Investing Cash Flow	-$146.9Mn/m	-$149.8Mn/m	-$117.1Mn/m	-$134.1Mn/m	-$93.8M-4500.0%	-$49.6Mn/m	-$42.9Mn/m	-$27.2Mn/m
Financing Cash Flow	$47.8M+1365.9%	$69.3Mn/m	$56.7M-22.3%	$26.5Mn/m	$3.3Mn/m	-$33.3Mn/m	$73.0Mn/m	-$28.5M-139.3%
Dividends Paid	$22.5M+11.3%	$22.6M+16.0%	$22.6M+16.0%	$22.3M+14.9%	$20.2M+14.8%	$19.5M+15.9%	$19.5M+15.8%	$19.5M+15.9%

Not reported in any period shown, so not listed: Share Buybacks.

HLNE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HLNE quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Net Margin	32.8%+2.3pp	30.5%+5.1pp	25.4%+4.8pp	20.6%-19.0pp	39.7%+11.0pp	28.7%+6.5pp	22.2%+8.9pp	13.3%+6.2pp	7.1%+6.8pp	0.3%	N/A
Return on Equity	27.2%-3.1pp	30.3%+3.5pp	26.8%+0.6pp	26.3%-15.8pp	42.1%+0.9pp	41.2%+1.9pp	39.3%+8.8pp	30.5%+8.3pp	22.1%+21.1pp	1.0%	N/A
Return on Assets	10.8%-2.0pp	12.9%+1.8pp	11.1%+1.5pp	9.6%-1.7pp	11.3%+2.6pp	8.6%-4.2pp	12.8%+3.5pp	9.3%+3.4pp	5.9%+5.6pp	0.3%	N/A
Debt-to-Equity	0.30-0.1x	0.400.0x	0.37-0.1x	0.51-0.1x	0.62-0.1x	0.69+0.2x	0.48-0.2x	0.64-0.4x	1.07-0.3x	1.40	N/A
Liabilities-to-Equity	1.52+0.4x	1.07-0.1x	1.13-0.2x	1.36-1.4x	2.73-1.0x	3.77+2.2x	1.53-0.2x	1.73-0.3x	2.01-0.6x	2.56	N/A
Asset Turnover	0.33-0.1x	0.420.0x	0.440.0x	0.46+0.2x	0.280.0x	0.30-0.3x	0.58-0.1x	0.70-0.1x	0.83+0.1x	0.75	N/A
FCF Margin	55.2%+14.7pp	40.5%+20.7pp	19.8%-22.1pp	42.0%-1.8pp	43.8%-5.9pp	49.6%+7.9pp	41.7%-0.4pp	42.1%+3.4pp	38.7%-6.0pp	44.7%	N/A

Metric	Q1'2710-Q	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Net Margin	29.2%-1.3pp	34.2%+8.7pp	29.4%-2.1pp	37.1%+0.5pp	30.5%+0.6pp	25.5%-1.9pp	31.5%+15.9pp	36.6%+3.5pp
Return on Equity	8.6%+1.5pp	7.2%+0.2pp	6.7%-1.5pp	8.6%-0.5pp	7.1%-3.3pp	7.0%-2.2pp	8.2%+4.0pp	9.1%0.0pp
Return on Assets	3.2%+0.2pp	2.9%-0.1pp	2.7%-0.6pp	3.6%-0.3pp	3.0%-1.3pp	3.0%-0.8pp	3.3%+1.7pp	3.9%+0.8pp
Debt-to-Equity	0.29-0.1x	0.30-0.1x	0.32-0.1x	0.350.0x	0.380.0x	0.400.0x	0.450.0x	0.32-0.1x
Liabilities-to-Equity	1.70+0.6x	1.52+0.4x	1.47+0.4x	1.000.0x	1.06-0.1x	1.07-0.1x	1.12-0.1x	1.03-0.9x
Asset Turnover	0.110.0x	0.080.0x	0.090.0x	0.100.0x	0.100.0x	0.120.0x	0.110.0x	0.110.0x
FCF Margin	27.4%-45.1pp	52.3%+34.2pp	36.5%+1.6pp	61.7%-15.5pp	72.5%+32.7pp	18.1%+6.7pp	34.9%+66.5pp	77.2%+18.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Hamilton Lane Incorporated HLNE	FY2026	$759.0M	$249.2M	32.8%	$5.5B	84/100
StepStone Group Inc. STEP	FY2026	$2.0B	-$535.8M	-26.9%	$5.4B	50/100
Affiliated Managers Group AMG	FY2025	$2.1B	$716.6M	34.5%	$9.9B	69/100
Blue Owl Capital Corporation OBDC	FY2025	N/A	$627.4M	N/A	$5.0B	—
Blackstone Secured Lending Fund BXSL	FY2025	N/A	$563.5M	N/A	$5.4B	—

Where Hamilton Lane Incorporated Ranks

Frequently Asked Questions

What is Hamilton Lane Incorporated's annual revenue?

Hamilton Lane Incorporated (HLNE) reported $759.0M in total revenue for fiscal year 2026. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hamilton Lane Incorporated's revenue growing?

Hamilton Lane Incorporated (HLNE) revenue grew by 6.5% year-over-year, from $713.0M to $759.0M in fiscal year 2026.

Is Hamilton Lane Incorporated profitable?

Yes, Hamilton Lane Incorporated (HLNE) reported a net income of $275.9M over the trailing 12 months to June 30, 2026. In fiscal year 2026 it reported a net income of $249.2M, with a net profit margin of 32.8%.

How much debt does Hamilton Lane Incorporated have?

As of fiscal year 2026, Hamilton Lane Incorporated (HLNE) had $371.9M in cash and equivalents against $278.4M in long-term debt.

What is Hamilton Lane Incorporated's net profit margin?

Hamilton Lane Incorporated (HLNE) had a net profit margin of 32.8% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Hamilton Lane Incorporated's return on equity (ROE)?

Hamilton Lane Incorporated (HLNE) has a return on equity of 27.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Hamilton Lane Incorporated's free cash flow?

Hamilton Lane Incorporated (HLNE) generated $419.1M in free cash flow during fiscal year 2026. This represents a 45.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hamilton Lane Incorporated's operating cash flow?

Hamilton Lane Incorporated (HLNE) generated $424.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Hamilton Lane Incorporated's total assets?

Hamilton Lane Incorporated (HLNE) had $2.3B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Hamilton Lane Incorporated's capital expenditures?

Hamilton Lane Incorporated (HLNE) invested $5.8M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

What is Hamilton Lane Incorporated's debt-to-equity ratio?

Hamilton Lane Incorporated (HLNE) had a debt-to-equity ratio of 0.30 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Hamilton Lane Incorporated's liabilities-to-equity ratio?

Hamilton Lane Incorporated (HLNE) had a liabilities-to-equity ratio of 1.52 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Hamilton Lane Incorporated's return on assets (ROA)?

Hamilton Lane Incorporated (HLNE) had a return on assets of 10.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Hamilton Lane Incorporated's P/E ratio?

Hamilton Lane Incorporated (HLNE) trades at 20.0x earnings, its market capitalization divided by $275.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $5.5B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Hamilton Lane Incorporated's price-to-sales ratio?

Hamilton Lane Incorporated (HLNE) trades at 6.4x sales, its market capitalization divided by $858.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $5.5B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Hamilton Lane Incorporated's Piotroski F-Score?

Hamilton Lane Incorporated (HLNE) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Hamilton Lane Incorporated's earnings high quality?

Hamilton Lane Incorporated (HLNE) has an earnings quality ratio of 1.71x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Hamilton Lane Incorporated?

Hamilton Lane Incorporated (HLNE) scores 84 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Hamilton Lane Incorporated it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.